^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SynKIR-110

    i
    Company:
    HLB Bio Group, University of Pennsylvania
    Drug class:
    Mesothelin-targeted CAR-T immunotherapy
    Related drugs: